Is the treatment listed below routinely available to patients according to it’s NICE TAG?

Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion [TA409] Yes

Confirmation means that patients do not have to use Individual Funding Requests to access this treatment.

Please could you send RNIB your commissioning policy for cataract surgery. Please indicate the review date of this policy.

This is attached and is reviewed annually Clinical Commissioning Group Policy for Cataracts